Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Handel & varor |
| Industri | Dagligvaror |
2024-08-05 21:44:14
Fornebu, 5 August 2024 - On 3 July 2024, Aker BioMarine ASA announced that it
has entered into an agreement with American Industrial Partners and Aker Capital
AS for the sale of Aker BioMarine ASA's ownership position in the Feed
Ingredients business. Closing of the transaction was subject to obtaining the
necessary competition clearances.
The transaction has now been cleared by all relevant competition authorities and
completion of the transaction is expected to take place during the third quarter
of 2024.
For further information, please contact:
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.